A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

In a small study, researchers transplanted stem cells into the brains of 12 Parkinson’s patients, stopping progression and ...

A treatment that could replenish cells in the brains of Parkinson’s disease patients caused no major negative reactions in ...

DelveInsight’s analysis forecasts Parkinson’s disease market growth due to the introduction of emerging therapies, expecting a rise in market size during the study period (2020–2034). The anticipated ...

April is Parkinson’s Awareness Month, a time to shed light on a condition that affects over 10 million people globally.

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Parkinson’s disease is a serious brain condition that slowly affects movement, balance, and coordination. Unfortunately, most ...

Mounting evidence suggests there might be two separate types of the world’s fastest-growing neurological condition. Can this ...

Parkinson’s Disease is a neurodegenerative disorder that affected predominately the Dopamine-producing neurons in a specific ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...

Parkinson's disease patients in SC take drugs to help ease symptoms but can often be left on a yo-yo of up and down time. A ...

About one-third of individuals with Parkinson’s disease experienced anxiety, and many of them reported that it disrupted ...